Research Article

The role of biochemical markers in predicting pre-eclampsia

Volume: 64 Number: 2 June 10, 2025
EN TR

The role of biochemical markers in predicting pre-eclampsia

Abstract

Aim: The aim of our study was to evaluate the role of biochemical markers in predicting preeclampsia. Materials and Methods: 7240 women whose pregnancy follow-ups and deliveries were carried out by us between March 2018 and March 2024 were retrospectively screened. Patients in the study group consisted of 102 women diagnosed with preeclampsia at <34 weeks of gestation, and patients in the control group consisted of 118 women who gave birth at ≥37 weeks of gestation. Demographic characteristics and obstetric and biochemical outcomes of the two groups were compared with each other. Results: The body mass index (BMI) value was significantly higher in the preeclampsia group compared with the controls group (p=0.016). The birth weight value was significantly lower in the preeclampsia group compared with the controls group (p<0.001). The gestational week at delivery was significantly lower in the preeclampsia group compared with the controls group (p<0.001). Lymphocyte and platelet counts were significantly lower in the preeclampsia group compared with the controls group (p<0.001 and p<0.001, respectively). NLR and SII value were significantly higher in the preeclampsia group compared with the controls group (p=0.022, p<0.001, respectively). Conclusion: Our study reveals important clinical and laboratory differences in preeclamptic pregnancies. Increased inflammatory markers were found to be a feature of preeclamptic pregnancies and are consistent with the existing literature. Our findings can be used to determine early diagnosis and comprehensive management strategies to minimize the risks associated with preeclampsia.

Keywords

References

  1. Choi Y, Jeon Y, Cho S, Park T, Lee WI, Kim Y, et al. Mean Platelet Volume in Patients with Preeclampsia: Single Center Study and Literature Review. Clin Lab. 2016;62(09/2016).
  2. Metz TD, Berry RS, Fretts RC, Reddy UM, Turrentine MA. Obstetric Care Consensus #10: Management of Stillbirth. Am J Obstet Gynecol. 2020 Mar;222(3):B2–20.
  3. Romero R, Lockwood C, Oyarzun E, Hobbins JC. Toxemia: new concepts in an old disease. Semin Perinatol. 1988 Oct;12(4):302–23.
  4. Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. J Leukoc Biol. 2013 Apr 30;94(2):247–57.
  5. Kirbas A, Biberoglu E, Daglar K, İskender C, Erkaya S, Dede H, et al. Neutrophil-to-lymphocyte ratio as a diagnostic marker of intrahepatic cholestasis of pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2014 Sep;180:12–5.
  6. Arbel Y, Finkelstein A, Halkin A, Birati EY, Revivo M, Zuzut M, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis. 2012 Dec;225(2):456–60.
  7. Guthrie GJK, Charles KA, Roxburgh CSD, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer. Crit Rev Oncol Hematol. 2013 Oct;88(1):218–30.
  8. Atlıhan U, Yavuz O, Avşar HA, Ata C, Erkılınç S, Bildacı TB. Vitamin D evaluation in adenomyosis: A retrospective cross-sectional study. Turk J Obstet Gynecol. 2024 Jun;21(2):98-103. doi:10.4274/tjod.galenos.2024.41662.

Details

Primary Language

English

Subjects

Obstetrics and Gynaecology

Journal Section

Research Article

Publication Date

June 10, 2025

Submission Date

December 27, 2024

Acceptance Date

March 10, 2025

Published in Issue

Year 1970 Volume: 64 Number: 2

Vancouver
1.Ufuk Atlıhan, Begüm Ertan, Mehmet Emre Peker, Can Ata, Onur Yavuz, Hüseyin Aytuğ Avşar, Alper İleri, Tevfik Berk Bıldacı, Selçuk Erkılınç. The role of biochemical markers in predicting pre-eclampsia. EJM. 2025 Jun. 1;64(2):324-9. doi:10.19161/etd.1608129

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.